Computer-guided treatment selection for older adults with tough depression
Part of Mental health clinical trials.
This study tests a computer-based tool to help choose the next medication for older adults with stubborn depression. It may help match you with a treatment (aripiprazole or bupropion) that is more likely to work for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years old or older.
- You must have major depression that hasn't improved with at least two earlier treatments.
- You need to be taking an antidepressant at a steady dose for at least 4 weeks before starting.
- You cannot have dementia, bipolar disorder, schizophrenia, or a recent serious substance use problem.
- You must not be at high risk for suicide right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study tests lumateperone, a new medication added to your current antidepressant, to help treat depression that hasn't improved with other treatments. It's designed for people age 60 and older who have tried at least two antidepressants without success.
This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.
This trial tests if using an algorithm to guide treatment works better than standard care for people whose depression hasn't gotten better with previous treatments. It aims to find a more effective approach for those with treatment-resistant depression.
This study tests a new way of choosing antidepressants for people with major depression. It's designed for adults aged 19–65 who have moderate to severe depression and are either starting a new antidepressant or have been off psychiatric meds for at least a month.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.